On Friday, Aptevo Therapeutics Inc (NASDAQ: APVO) was -0.69% drop from the session before settling in for the closing price of $0.25. A 52-week range for APVO has been $0.14 – $15.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -17.88% over the past five years. When this article was written, the company’s average yearly earnings per share was at -94.84%. With a float of $9.42 million, this company’s outstanding shares have now reached $9.42 million.
Let’s look at the performance matrix of the company that is accounted for 40 employees. In terms of profitability, gross margin is 51.66%, operating margin of -2877.16%, and the pretax margin is -2799.0%.
Aptevo Therapeutics Inc (APVO) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Aptevo Therapeutics Inc stocks. The insider ownership of Aptevo Therapeutics Inc is 0.06%, while institutional ownership is 20.85%.
Aptevo Therapeutics Inc (APVO) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -22 earnings per share (EPS) during the time that was better than consensus figure (set at -33) by 11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -94.84% per share during the next fiscal year.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
You can see what Aptevo Therapeutics Inc (APVO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -47.12, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -1.17 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Aptevo Therapeutics Inc (NASDAQ: APVO) saw its 5-day average volume 61.25 million, a positive change from its year-to-date volume of 3.85 million. As of the previous 9 days, the stock’s Stochastic %D was 31.24%. Additionally, its Average True Range was 0.06.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 14.26%, which indicates a significant decrease from 28.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 235.00% in the past 14 days, which was higher than the 191.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2610, while its 200-day Moving Average is $2.1367. Nevertheless, the first resistance level for the watch stands at $0.2571 in the near term. At $0.2689, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2829. If the price goes on to break the first support level at $0.2313, it is likely to go to the next support level at $0.2173. Assuming the price breaks the second support level, the third support level stands at $0.2055.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
There are 4,081K outstanding shares of the company, which has a market capitalization of 2.31 million. As of now, sales total 0 K while income totals -17,410 K. Its latest quarter income was 0 K while its last quarter net income were -5,880 K.
